Sanara MedTech Inc.
$20.62
▼
-0.06%
2026-04-21 09:30:00
sanaramedtech.com
NCM: SMTI
Explore Sanara MedTech Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$190.4 M
Current Price
$20.62
52W High / Low
$35.95 / $16.05
Stock P/E
—
Book Value
$0.66
Dividend Yield
—
ROCE
16.84%
ROE
-1.75%
Face Value
—
EPS
$-0.05
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
108
Beta
1.1
Debt / Equity
812.73
Current Ratio
1.8
Quick Ratio
1.59
Forward P/E
-14.13
Price / Sales
1.47
Enterprise Value
$183.14 M
EV / EBITDA
15.51
EV / Revenue
1.78
Rating
Strong Buy
Target Price
$36
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Leverage is relatively high.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | LeMaitre Vascular, Inc. | $115 | 44.97 | $2.6 B | 0.87% | 11.72% | 15.8% | $118.01 / $78.01 | $17.28 |
| 2. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
| 3. | NEXGEL, Inc. | $0.64 | — | $6.98 M | — | -41.75% | -52.74% | $2.99 / $0.56 | $0.64 |
| 4. | Bausch + Lomb Corporation | $16.76 | — | $5.94 B | — | 1.55% | -5.39% | $18.91 / $10.45 | $18.2 |
| 5. | KORU Medical Systems, Inc. | $4.26 | — | $200.78 M | — | -14.86% | -15.58% | $6.61 / $2.08 | $0.37 |
| 6. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 7. | West Pharmaceutical Services, Inc. | $274.81 | 40.51 | $19.81 B | 0.33% | 17.6% | 16.86% | $322.34 / $193.05 | $44.11 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 27.55 M | 26.33 M | 25.83 M | 23.43 M | 26.31 M | — |
| Operating Profit | 2.89 M | 2.94 M | -0.03 M | -2.08 M | -2.38 M | — |
| Net Profit | -1.61 M | -30.41 M | -2.01 M | -3.53 M | -1.54 M | — |
| EPS in Rs | -0.18 | -3.32 | -0.22 | -0.38 | -0.17 | -0.34 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 103.12 M | 86.67 M | 64.99 M | 45.84 M |
| Operating Profit | 9.15 M | 1.24 M | -7.67 M | -12.23 M |
| Net Profit | -37.56 M | -9.66 M | -4.3 M | -7.94 M |
| EPS in Rs | -4.1 | -1.05 | -0.47 | -0.87 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 72.94 M | 88.09 M | 73.87 M | 61.04 M |
| Total Liabilities | 67.01 M | 49.18 M | 29.28 M | 19.32 M |
| Equity | 5.94 M | 39.4 M | 44.83 M | 41.83 M |
| Current Assets | 33.54 M | 33.31 M | 19.01 M | 20.62 M |
| Current Liabilities | 18.63 M | 15.29 M | 13.77 M | 12.81 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 6.79 M | -0.02 M | -3.25 M | -5.55 M |
| Investing CF | -14.97 M | -6.61 M | -10.21 M | -3.51 M |
| Financing CF | 8.89 M | 17.37 M | 9.64 M | -0.63 M |
| Free CF | 2.14 M | -0.25 M | -3.51 M | -6.3 M |
| Capex | -4.65 M | -0.23 M | -0.27 M | -0.75 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 33.36% | 41.77% | — | — |
| Earnings Growth % | -124.59% | 45.79% | — | — |
| Profit Margin % | -11.15% | -6.62% | -17.31% | — |
| Operating Margin % | 1.44% | -11.79% | -26.68% | — |
| Gross Margin % | 90.61% | 87.92% | 86.12% | — |
| EBITDA Margin % | 7.05% | -0.44% | -25.23% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.